Texas Methylphenidate Lawyer
Methylphenidate is one of the most common treatments for children with ADHD, but it can also have severe side effects. The FDA has received 15 reports of priapism (prolonged and unwanted erections) that can cause permanent erectile dysfunction. Other serious...
Texas Methylin Lawyer
Methylin (methylphenidate) is a prescription medication for adults and children with attention-deficit hyperactivity disorder (ADHD). Unfortunately, side effects of Methylin in children can include growth delays, cardiovascular events, priapism, and permanent sexual dysfunction. What is Methylin? Methylin is a short-acting,...
Texas Ritalin LA Lawyer
Ritalin LA (methylphenidate) is a long-acting prescription medication for the treatment of ADHD (attention-deficit hyperactivity disorder). Many patients on Ritalin LA are children, which is concerning because it can have serious side effects like growth delays, seizures, psychiatric disorders, cardiovascular...
Texas Focalin XR Lawyer
Focalin XR is a popular treatment for attention-deficit hyperactivity disorder (ADHD) in children. Recently, the FDA has warned that Focalin XR and other ADHD drugs may increase a child’s risk of priapism -- a long-lasting erection that can cause permanent...
Magic Slim, Other Diet Pills Recalled by MyNicKnaxs, LLC
February 17, 2014 -- MyNicKnaxs, LLC and the FDA have announced a recall for several weigh-loss pills because they contain undeclared pharmaceutical drugs, including sibutramine and phenolphthalein or a combination of both. No injuries have been reported, but consumptions of...
Texas Daytrana Lawyer
Daytrana (methylphenidate) is a popular treatment for ADHD (attention-deficit hyperactivity disorder) that has been sold by Noven Pharmaceuticals since 2006. The FDA has recently warned that Daytrana may increase the risk of priapism (long-lasting erections), cardiovascular events, and serious psychiatric...
Texas Onglyza Heart Failure Lawyer
Onglyza has been linked to a 27% increased risk of heart failure, according to a recent clinical trial.
Onglyza Linked to 27% Increased Risk of Heart Failure
Onglyza and Kombiglyze XR have been linked to a 27% increased risk of hospitalization for heart failure, according to a study published in the New England Journal of Medicine.
Controversial Pradaxa Blood Test Study Conclusions Concealed
Documents unsealed in federal court last week indicate that Boehringer Ingelheim may have concealed conclusions from a study suggesting that some patients may need blood tests while using Pradaxa.